{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:44:17Z","timestamp":1790066657760,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.atherosclerosis.2018.03.030","type":"journal-article","created":{"date-parts":[[2018,3,17]],"date-time":"2018-03-17T00:46:54Z","timestamp":1521247614000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Effect of simvastatin and ezetimibe on suPAR levels and outcomes"],"prefix":"10.1016","volume":"272","author":[{"given":"Gethin W.","family":"Hodges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper N.","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Boman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Antero","family":"Kes\u00e4niemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Eugen-Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders M.","family":"Greve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen L.","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Wachtell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm.4242","article-title":"Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease","volume":"23","author":"Hahm","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","article-title":"suPAR: the molecular crystal ball","volume":"27","author":"Thun\u00f8","year":"2009","journal-title":"Dis. Markers"},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib3","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cjca.2015.03.023","article-title":"SuPAR: a new biomarker for cardiovascular disease?","volume":"31","author":"Hodges","year":"2015","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib4","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.cjca.2016.04.012","article-title":"SuPAR predicts cardiovascular events and mortality in patients with asymptomatic aortic stenosis","volume":"32","author":"Hodges","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.12688\/f1000research.10510.1","article-title":"Unwinding focal segmental glomerulosclerosis","volume":"6","author":"Peev","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib6","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nm.4362","article-title":"Tripartite complex of suPAR, APOL1 risk variants and \u03b1v\u03b23 integrin on podocytes mediates chronic kidney disease","volume":"23","author":"Hayek","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib8","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib9","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.337.6099.1158","article-title":"Cardiovascular disease. Massive trials to test inflammation hypothesis","volume":"337","author":"Couzin-Frankel","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib11","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(09)60447-5","article-title":"Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial","volume":"373","author":"Ridker","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000152","article-title":"High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: a SEAS substudy","volume":"2","author":"Blyme","year":"2015","journal-title":"Open Heart"},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib13","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.amjcard.2006.10.064","article-title":"Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study","volume":"99","author":"Rosseb\u00f8","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jmv.21114","article-title":"Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in hiv-infected patients receiving highly active antiretroviral therapy","volume":"80","author":"Andersen","year":"2008","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2307\/2533148","article-title":"Pattern mixture models for multivariate incomplete data with covariates","volume":"52","author":"Little","year":"1996","journal-title":"Biometrics"},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib17","article-title":"Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand","volume":"18","author":"Stach","year":"2011","journal-title":"Cardiol. J."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.carpath.2013.04.005","article-title":"Treatment with beta-blockers is associated with lower levels of lp-pla2 and suPAR in carotid plaques","volume":"32","author":"Asciutto","year":"2013","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosis.2016.01.001","article-title":"Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: a randomized trial","volume":"246","author":"Pedersen","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ijo.2017.9","article-title":"Impact of lifestyle intervention for obese women during pregnancy on maternal metabolic and inflammatory markers","volume":"41","author":"Renault","year":"2017","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/eci.12593","article-title":"Plasma suPAR is lowered by smoking cessation: a randomized controlled study","volume":"46","author":"Eugen-Olsen","year":"2016","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","article-title":"Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population","volume":"268","author":"Eugen-Olsen","year":"2010","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2018.03.030_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1478-3231.2011.02665.x","article-title":"Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis","volume":"32","author":"Zimmermann","year":"2012","journal-title":"Liver Int."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018301552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018301552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T02:43:32Z","timestamp":1719888212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018301552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":23,"alternative-id":["S0021915018301552"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.03.030","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of simvastatin and ezetimibe on suPAR levels and outcomes","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}